US Executive Officer Management Changes SEC — April 23, 2026

23-04-2026

SES AI Corp reported Q1 2026 revenue of $6.7 million, up 47% QoQ from Q4 2025 ($4.6 million implied) and 16% YoY from Q1 2025 ($5.8 million), driven by ESS via UZ Energy, drone samples, and Molecular Universe subscriptions, while reaffirming FY2026 revenue guidance of $30-35 million and announcing a $20 million multiyear contract with ATG EPower. Gross margin improved to 18.1% QoQ from 11.3% but declined sharply YoY from 78.7% due to revenue mix shift to lower-margin products; operating expenses fell to $19.1 million YoY from $27.8 million but net loss held steady at $12.1 million similar to Q1 2025. The company also announced CFO Jing Nealis transitioning out effective April 27, 2026, with Yi (Ray) Liu appointed as successor.

• ·Q1 2026 GAAP net loss per share: $(0.04), unchanged YoY
• ·Adjusted EBITDA loss: $12.8M in Q1 2026 vs $13.8M in Q4 2025 (improvement) and $16.5M in Q1 2025
• ·Expected FY2026 blended gross margin: approximately 15%
• ·Routine S-3 shelf registration to be filed with 10-Q as current expires April 28, 2026
• ·Total assets: $253.5M as of March 31, 2026 vs $272.6M as of Dec 31, 2025

23-04-2026

Texas Capital Bancshares reported first quarter 2026 net income available to common stockholders of $69.5 million ($1.56 per diluted share), up 63% YoY from $42.7 million but down 28% QoQ from $96.3 million ($2.12 per share), amid higher provisions for credit losses ($16.0 million) and net charge-offs ($17.4 million). The company initiated its first quarterly common stock cash dividend of $0.20 per share and highlighted revenue diversification with non-interest income up 42% YoY to $69.3 million, though net interest income fell 5% QoQ to $254.7 million and efficiency ratio worsened to 65.9%. Capital remains strong with CET1 at 12.0%, total assets grew to $33.5 billion, and book value per share rose 11% YoY to $75.71.

• ·Criticized loans $650.6 million at March 31, 2026, up from $634.9 million at Dec 31, 2025 but down from $762.9 million at March 31, 2025.
• ·Non-accrual LHI $144.9 million (0.58% of total LHI) at March 31, 2026, up from $116.9 million (0.49%) QoQ and $93.6 million (0.42%) YoY.
• ·Allowance for credit losses to total LHI 1.32% at March 31, 2026, down from 1.38% QoQ and 1.48% YoY.
• ·Common stock repurchased at weighted average $96.82 per share.
• ·Preferred dividend $14.375 per share Series B, payable June 15, 2026.

23-04-2026

Indaptus Therapeutics, Inc. appointed Tim Ruan and Dr. Yi Zhang as independent Class II directors effective April 22, 2026, with Mr. Ruan joining the Audit Committee as a financial expert and Dr. Zhang joining the Nominating Committee. Both bring extensive experience in finance/biotech (Ruan from Ocumension Therapeutics, Goldman Sachs, Morgan Stanley) and IP/life sciences (Zhang from JunHe). On the same day, director Matthew McMurdo resigned with no disagreements on company matters.

• ·Appointments decided on April 17, 2026; Director Agreements and Indemnification Agreements executed effective April 22, 2026 (Exhibits 10.1 and 10.2).
• ·Mr. Ruan qualifies as an 'audit committee financial expert' per Item 407(d)(5)(ii) of Regulation S-K.
• ·No arrangements, family relationships, or material interests under Item 404(a) of Regulation S-K for new directors.
• ·Junyi Dai and Qinglai Lu serve as Class III directors (appointed March 18 and April 8, 2026, terms to 2027 annual meeting).

23-04-2026

On April 21, 2026, the Board of Directors of Capstone Green Energy Holdings, Inc. approved an amendment to the 2023 Equity Incentive Plan, increasing the maximum number of shares of common stock issuable from 4,000,000 to 7,000,000. This change expands the equity pool available for incentives but introduces potential shareholder dilution. The amendment is filed as Exhibit 10.1.

• ·Form 8-K filed on April 23, 2026; event reported as of April 21, 2026; signed April 22, 2026
• ·Common stock trades as CGEH on OTCQX, par value $0.001 per share

23-04-2026

Teledyne Technologies Incorporated filed a Restated Certificate of Incorporation on April 23, 2026, restating and amending its original certificate filed on August 23, 1999. The document authorizes 125,000,000 shares of Common Stock and 15,000,000 shares of Preferred Stock, both with a par value of $0.01 per share, and outlines governance provisions including board management authority, indemnification rights, and restrictions on stockholder actions to meetings only. No financial performance metrics or period-over-period changes are reported.

• ·Registered office: 1209 Orange Street, Wilmington, New Castle County, Delaware 19801.
• ·Stockholder actions required at meetings; no written consents permitted.
• ·Special meetings callable by Board, Chairman, CEO, or Secretary upon 25% stockholder demand.
• ·Director liability limited except for duty of loyalty breaches, bad faith, etc.

23-04-2026

BridgeBio Oncology Therapeutics, Inc. (BBOT) announced the appointment of Pedro J. Beltran, PhD, as Chief Executive Officer, Idan Elmelech as Chief Operating Officer, and Neil Kumar, PhD, as Executive Chairman, effective April 20, 2026. Former CEO Eli Wallace, PhD, will transition to Senior Adviser. The changes are positioned to support BBOT's clinical-stage assets entering Phase 1b expansions and combinations in RAS and PI3Kα malignancies.

• ·Announcement date: April 22, 2026
• ·Filing date: April 23, 2026
• ·Dr. Beltran joined BridgeBio Pharma in 2020, became CSO of BBOT in July 2023; prior roles at UNITY Biotechnology and Amgen
• ·BBOT focused on RAS-pathway malignancies with three clinical assets advancing to Phase 1b expansions

23-04-2026

Nomadar Corp. (NASDAQ: NOMA) appointed former NBA star José Manuel Calderón to its Board of Directors effective April 23, 2026, to advance its global sports, technology, infrastructure, and capital markets strategy, particularly supporting the JP Financial Arena project in southern Spain. The move follows recent milestones including securing approximately $7.3 million in new capital and a binding agreement to purchase 130,000 square meters of land for the arena. Calderón's experience strengthens governance and institutional positioning amid Nomadar's expansion in Europe.

• ·Nomadar is a subsidiary of Cádiz CF, a 115-year-old La Liga soccer club.
• ·Calderón serves on the board of another Nasdaq-listed company.

23-04-2026

Cass Information Systems reported Q1 2026 net income of $8.8 million and diluted EPS of $0.67, with adjusted EPS rising 26.9% YoY to $0.66 amid net interest margin expansion to 3.95% from 3.75% and facility dollar volumes up 7.4% YoY. However, processing fees declined 4.5% YoY due to lower transportation (-3.1%) and facility (-4.4%) invoice volumes, while personnel expenses remained flat. Management highlighted ongoing efficiency initiatives, strong asset quality with non-performing loans down 55.1%, and a quarterly dividend of $0.32 per share.

• ·Repurchased 64,802 shares at weighted average price of $44.34.
• ·Quarterly dividend of $0.32 per share payable June 15, 2026 to shareholders of record June 5, 2026.
• ·No loan charge-offs; allowance for credit losses to loans ratio of 1.27%.
• ·Non-performing loans totaled $3.1 million at March 31, 2026.
• ·Expects loan growth of 6-8% for full year 2026.

23-04-2026

Charter Communications, Inc. held its 2026 Annual Meeting of Stockholders on April 21, 2026, where all 13 director nominees were elected with strong majorities (ranging from 95% to 99% For votes among votes cast). Stockholders approved an amendment to the 2019 Stock Incentive Plan increasing available shares by 16.0 million, ratified KPMG LLP as independent auditors (99% For), and approved named executive officer compensation on an advisory basis (76% For); however, a stockholder proposal for a political expenditures report was rejected (18% For). No other matters were voted on.

• ·118,382,741 shares of Class A common stock and 1 share of Class B common stock (15,511,283 votes) represented at the meeting.
• ·Plan amendment: 90,820,528 For, 37,522,506 Against, 66,927 Abstain.
• ·NEO compensation: 98,047,867 For, 30,289,182 Against, 72,912 Abstain.
• ·Auditor ratification: 131,975,231 For, 1,840,776 Against, 78,017 Abstain.
• ·Political expenditures proposal: 23,286,541 For, 104,891,888 Against, 231,532 Abstain.

23-04-2026

Meridian Bank announced the retirement of George Collier from its Board of Directors after 21 years of service as a founding board member and initial investor. Collier's financial expertise from his role as Executive Vice President, Chief Financial Officer, and Director at Streamlight, Inc. contributed to the bank's stability and growth. President and CEO Chris Annas praised Collier's lasting legacy and impact on the organization.

• ·Collier served as director since 2004
• ·Meridian Bank serves Pennsylvania, New Jersey, Delaware, Maryland, and Florida
• ·Contact: Christopher J. Annas, CAnnas@meridianbanker.com, 484.568.5001

23-04-2026

On April 17, 2026, Ana Hooker resigned from the Board of Directors of Exagen Inc., effective immediately, reducing the board size from eight (8) to seven (7) members. Her resignation was not due to any disagreement with the company's operations, policies, or practices; she served on the Audit Committee and as chair of the Nominating and Corporate Governance Committee. Following her departure, the board committees were updated with Paul Kim as Audit Committee chair and financial expert, and Frank Stokes as Compensation Committee chair.

• ·Exagen Inc. is incorporated in Delaware, Commission File Number 001-39049, IRS Employer ID 20-0434866, headquartered at 1261 Liberty Way, Vista, CA 92081.
• ·Common Stock trades as XGN on The Nasdaq Global Market, par value $0.001 per share.
• ·Filing signed by Jeffrey G. Black, CFO, on April 23, 2026.

23-04-2026

F&M Trust, a subsidiary of Franklin Financial Services Corp. (FRAF), announced the promotion of Chad Carroll to President and Chief Operating Officer, effective April 28, 2026, while he also joins the F&M Trust Board of Directors. Carroll, who joined in 2023 as Executive Vice President and Chief Operating Officer and was promoted to Senior Executive Vice President in January 2026, will oversee day-to-day operations and support strategic growth. The bank manages $2.2 billion in assets across 23 community-banking locations.

• ·F&M Trust headquartered in Chambersburg, Pa., with locations in Franklin, Cumberland, Dauphin, Fulton, and Huntingdon Counties in Pennsylvania, and Washington County, Maryland.
• ·Carroll based out of the bank's corporate headquarters in Chambersburg.

23-04-2026

Lifeward Ltd. announced that Jeannine Lynch's employment as Vice President of Strategy and Market Access will terminate effective May 3, 2026, pursuant to notice on April 20, 2026, treated as without cause under her Employment Agreement dated July 9, 2021. Ms. Lynch will receive severance and benefits in accordance with the agreement, details of which were disclosed in the company's Form 10-K filed March 18, 2026. No successor has been named.

• ·Termination notice provided on April 20, 2026.
• ·Form 8-K filed on April 23, 2026.

23-04-2026

Patryk P. Goscianski resigned as Chief Financial Officer, principal financial and accounting officer, and Secretary of Burzynski Research Institute, Inc., effective April 17, 2026, with no disagreements on operations, policies, or practices. The Board appointed Stanislaw R. Burzynski, M.D., Ph.D., the Company's 83-year-old President, Chairman, and principal executive officer, as the new CFO, principal financial and accounting officer, and Secretary, effective the same date, with no additional compensation. Dr. Burzynski is the controlling stockholder and related to the other board members.

• ·Resignation letter dated April 16, 2026, filed as Exhibit 17.1.
• ·No related party transactions required to be disclosed under Item 404(a) of Regulation S-K other than the three referenced agreements.
• ·Biographical history of Dr. Burzynski and agreement descriptions incorporated by reference from Form 10-K for year ended February 28, 2025.
• ·Dr. Burzynski will serve as both principal executive officer and principal financial officer.

23-04-2026

Edison International (NYSE: EIX) and Southern California Edison elected M. Susan Hardwick as an independent director to both companies' boards, effective April 23, 2026. Hardwick, with over 35 years of experience including as former CEO of American Water Works Company, Inc., offers expertise in utility operations, finance, capital allocation, risk management, and regulatory affairs. Company leaders highlighted her alignment with priorities in safety, reliability, infrastructure planning, and clean energy delivery.

• ·Hardwick served as CEO of American Water Works from 2022 until retirement in May 2025.
• ·Previously held roles as president, executive vice president, and CFO at American Water; nearly two decades at Vectren in finance and leadership.
• ·Currently serves on boards of Core & Main, Inc., Tetra Tech, Inc., and New Jersey Resources Corporation.
• ·Holds bachelor’s degree from Indiana University and is a Certified Public Accountant (inactive).

23-04-2026

RPM International Inc. announced the appointment of Thomas C. Gentile, III, Chairman, CEO, and President of Hexcel Corporation, to its board of directors effective April 20, 2026, expanding the board to 13 members. Gentile, with prior leadership at Spirit AeroSystems, GE (including GE Capital, GE Healthcare Systems, and GE Aviation Services), McKinsey & Company, CBS, and General Motors, will serve on RPM's compensation committee. RPM Chairman and CEO Frank C. Sullivan highlighted Gentile's expertise in global manufacturing and industrial operations to support long-term growth.

• ·RPM operates across three reportable segments: consumer, construction products, and performance coatings.
• ·Gentile assumed CEO and president role at Hexcel in May 2024 and chairman in December 2024.
• ·Gentile earned bachelor’s degree in economics magna cum laude and MBA from Harvard University; studied international relations at London School of Economics.

23-04-2026

IQVIA Holdings Inc. held its 2026 Annual Meeting of Stockholders on April 23, 2026, electing all nine director nominees by majority vote, with support ranging from approximately 92% for Ari Bousbib to 99% for William G. Kaelin Jr., M.D. Stockholders approved the 2026 Incentive and Stock Award Plan by a vote of 96,987,612 for versus 51,006,455 against, ratified PricewaterhouseCoopers LLP as auditor overwhelmingly, and approved 2025 named executive officer compensation on an advisory basis (118,398,355 for versus 29,398,856 against). However, a stockholder proposal for separate Chairman and CEO roles failed decisively (36,717,802 for versus 111,154,252 against).

• ·Proposal No. 1 Director votes - Ari Bousbib: 138,448,357 For, 8,565,570 Against, 1,214,049 Abstain; Carol J. Burt: 135,795,078 For, 12,212,098 Against, 220,801 Abstain; John G. Danhakl: 142,605,129 For, 5,318,909 Against, 303,939 Abstain; James A. Fasano: 141,704,011 For, 6,303,043 Against, 220,922 Abstain; Colleen A. Goggins: 139,720,846 For, 8,288,024 Against, 219,107 Abstain; William G. Kaelin Jr., M.D.: 147,942,854 For, 64,869 Against, 220,254 Abstain; John. M. Leonard, M.D.: 143,748,610 For, 4,258,365 Against, 221,001 Abstain; Leslie Wims Morris: 147,058,789 For, 867,756 Against, 301,430 Abstain; Sheila A. Stamps: 147,357,181 For, 650,699 Against, 220,095 Abstain
• ·Proposal No. 2 NEO compensation: 118,398,355 For, 29,398,856 Against, 430,765 Abstain
• ·Proposal No. 3 Auditor ratification: 140,865,227 For, 14,140,721 Against, 212,076 Abstain
• ·Proposal No. 4 2026 Plan: 96,987,612 For, 51,006,455 Against, 233,909 Abstain
• ·Proposal No. 5 Separate Chairman/CEO: 36,717,802 For, 111,154,252 Against, 355,920 Abstain
• ·2026 Plan authorizes performance metrics including revenue, adjusted EBITDA, earnings per share, adjusted diluted earnings per share, cash flow, free cash flow as % of adjusted net income, relative total stockholder return

23-04-2026

Acadia Healthcare Company, Inc. (ACHC) appointed David Duckworth, former CFO from 2012-2023, as Interim CFO effective May 1, 2026, succeeding Todd Young who departs April 30, 2026, for a CFO role at a private equity-backed animal health company. The company reaffirmed its Q1 2026 guidance of $820-830 million revenue and $130-137 million Adjusted EBITDA, and full-year 2026 guidance of $3.37-3.45 billion revenue and $575-610 million Adjusted EBITDA, with no changes indicating stable outlook amid the leadership transition. As of December 31, 2025, Acadia operates 277 behavioral healthcare facilities with over 12,500 beds, 25,000 employees, and serves more than 84,000 patients daily.

• ·Q1 2026 Adjusted EPS guidance: $0.25 to $0.30
• ·Full-Year 2026 Adjusted EPS guidance: $1.30 to $1.55
• ·Q1 2026 results to be issued after market close on April 29, 2026; earnings call on April 30, 2026 at 9 a.m. EDT
• ·Search for permanent CFO ongoing
• ·Facilities in 40 states and Puerto Rico

23-04-2026

National Health Investors, Inc. (NHI) announced CFO John Spaid's retirement effective July 1, 2026, with Todd Siefert appointed as Executive Vice President Corporate Finance effective June 1, 2026, to succeed as CFO. Dana Hambly was promoted to Senior Vice President of Finance to support the transition. Leadership highlighted Spaid's contributions to a strong balance sheet and Siefert's 25+ years of REIT experience, positioning the company for continued growth.

• ·NHI established in 1991 as a self-managed REIT focusing on senior housing and medical facilities.
• ·Siefert began career as Senior Consultant at Booz Allen & Hamilton and Merger and Acquisition Analyst at U.S. Department of Justice — Antitrust Division.
• ·Annual Report on Form 10-K referenced for year ended December 31, 2025.

23-04-2026

BayCom Corp (NASDAQ: BCML) announced the appointment of Michael J. Perdue as a new director, effective April 22, 2026. Mr. Perdue brings over four decades of community banking leadership, including roles as President of Pacific Western Bank’s San Diego and Desert Regions, President of First Community Bancorp, and CEO/Director of Community Bancorp Inc. (NASDAQ: CMBC), with expertise in growth, acquisitions, and operations in Southern California. Company leadership, including Chairman Lloyd Kendall, Executive Vice Chairman Bill Black, and CEO Christopher Baron, highlighted his value to ongoing strategy execution.

• ·BayCom Corp operates through United Business Bank in California, Washington, New Mexico, and Colorado.
• ·Contact: Kevin L. Thompson, 925-476-1800, klthompson@ubb-us.com

23-04-2026

Tectonic Therapeutic, Inc. (NASDAQ: TECX) appointed Jessica Chutter to its Board of Directors, effective June 8, 2026. Ms. Chutter, with over four decades at Morgan Stanley including roles as Vice Chair of Healthcare Investment Banking and Chair of Biotechnology Investment Banking, advised on approximately $80 billion in capital raising and $85 billion in strategic transactions. The appointment aims to bolster strategic positioning as the company advances its two clinical programs targeting three indications and preclinical portfolio.

• ·Filing date: April 23, 2026
• ·Appointment effective date: June 8, 2026
• ·Ms. Chutter's prior roles: Managing Director (1998-February 2026), Vice Chair of Healthcare Investment Banking (2020-February 2026), Chair of Biotechnology Investment Banking (2010-February 2026)
• ·Ms. Chutter serves on boards of PTC Therapeutics, The Hospital for Sick Children, and Toronto Innovation Acceleration Partners
• ·Ms. Chutter holds an M.B.A. from Harvard Business School and a Bachelor of Arts in Commerce and Honors Economics from McGill University

23-04-2026

Corvus Pharmaceuticals, Inc. appointed Andrew C. Chan, M.D., Ph.D. as a Class II director and to the Nominating Committee, effective April 23, 2026, following a Board recommendation. Simultaneously, Scott Morrison resigned from the Board effective the same date after over a decade of service, including as Audit Committee Chairperson. Dr. Chan will receive a $35,000 annual Board retainer, $4,000 additional for committee service, and an initial stock option for 30,000 shares.

• ·Dr. Chan's Class II director term expires at the 2027 annual meeting of stockholders.
• ·Compensation earned quarterly and prorated for current quarter; eligible for subsequent equity awards.
• ·References Company's non-employee director compensation program (Exhibit 10.10 to 10-K filed March 12, 2026) and standard indemnification agreement (Exhibit 10.4 to same 10-K).

23-04-2026

On April 21, 2026, the Compensation Committee of Twin Vee PowerCats Co. approved an increase in the annual base salary of Vice President Preston Yarborough to $250,000. On April 22, 2026, the company entered into an amendment to his employment agreement, effective as of the original July 23, 2021 agreement, reflecting the salary increase and terminating a prior amendment dated June 27, 2024. The amendment is filed as Exhibit 10.1.

• ·The company is an emerging growth company under Rule 405 and Rule 12b-2.
• ·Securities registered: Common stock, par value $0.001 per share, trading symbol VEEE on Nasdaq Capital Market.

23-04-2026

Vaxart, Inc. (VXRT) announced the appointment of James Breitmeyer, M.D., Ph.D., to its Board of Directors on April 23, 2026, to strengthen clinical development and regulatory expertise for its oral vaccine platform. Dr. Breitmeyer brings over 35 years of biopharmaceutical experience, including leadership in clinical programs resulting in eight FDA product approvals across the US, Europe, and Japan. The appointment is viewed positively by Lead Independent Director Mark Watson, aligning with Vaxart's mission to advance pill vaccines for coronavirus, norovirus, influenza, and HPV.

• ·Dr. Breitmeyer previously served as President and CEO of Oncternal Therapeutics, Inc., President of Bavarian Nordic, Inc., and held senior roles at Eli Lilly, Cadence Pharmaceuticals.
• ·Dr. Breitmeyer earned M.D. and Ph.D. from Washington University School of Medicine, with postdoctoral fellowships at Harvard Medical School and Dana-Farber Cancer Institute.

23-04-2026

On April 20, 2026, Gerri Gold notified the Board of Climb Global Solutions, Inc. that she will retire from the Board and not stand for re-election at the 2026 annual meeting of stockholders, continuing to serve until the expiration of her term. Her decision was not due to any dispute or disagreement with the Company's operations, policies, or practices. The Board will reduce its size from five to four directors effective at the commencement of the Annual Meeting.

• ·The Board thanked Ms. Gold for her dedicated service and valuable contributions.

23-04-2026

Zura Bio Limited separated from its Chief Financial Officer, Principal Financial Officer, and Principal Accounting Officer, Eric Hyllengren, on April 20, 2026, with the departure unrelated to financial, operational, or reporting issues. In connection, the company entered a Separation Agreement providing three months of base salary as severance and COBRA premium reimbursement for up to six months. On the same date, the Board appointed Marlyn Mathew, current Vice President of Finance and Accounting, as the new Principal Accounting Officer and Principal Financial Officer, with an increased annual base salary of $366,415.

• ·Separation Agreement signed April 21, 2026; payments contingent on compliance and subject to offsets from other employment.
• ·Ms. Mathew, age 42, held role since June 2022; prior roles at Immunovant as Controller (2019-May 2022) and Assistant Controller (2018-2019); holds BS in Accounting from Rutgers University.
• ·No arrangements, understandings, family relationships, or Item 404(a) disclosable transactions for Ms. Mathew.

23-04-2026

Avantor, Inc. (NYSE: AVTR) announced the appointment of Ludovic Brellier as Executive Vice President, Bioscience & Medtech Products (BMP) & Chief Transformation Officer, effective May 1, 2026, to grow the BMP business, improve operations, and lead the Revival Management Office. Brellier joins from Danaher's Cytiva, where he was President of Hardware Solutions. Current BMP EVP Benoit Gourdier will remain until on or before the end of 2026 to ensure a smooth transition.

• ·Brellier previously served as President of Integrated Solutions & Services and VP Business Operations at Cytiva, and led the establishment of Cytiva as a standalone company and integration of Pall Life Sciences.
• ·Investor Relations contact: Chris.Fidyk@avantorsciences.com
• ·Global Media contact: Eric.VanZanten@avantorsciences.com (610-529-6219)

23-04-2026

Myseum.AI, Inc. (Nasdaq: MYSE) announced its acceptance into the AMD AI Developer Program, providing access to AMD Developer Cloud credits, advanced tools, training, and community resources to accelerate AI development. The company was featured as a 'Next Super Stock' by Wall Street Reporter, with CEO Darin Myman interviewed on AI platform innovations, user growth, and the Picture Party platform. This news follows the recent rebrand from DatChat Inc. to Myseum.AI, emphasizing privacy-first AI and social media technologies.

• ·Picture Party available on iOS App Store and Google Play; desktop version expected later in 2026.
• ·Press release dated April 17, 2026; SEC filing dated April 23, 2026.

23-04-2026

On April 20, 2026, USA Rare Earth, Inc. directors Mordechai Gutnick and General Paul Kern notified the Board they will not stand for reelection at the June 3, 2026 annual meeting, prompting the Board to reduce its size to six directors effective immediately before the meeting; their departures were not due to any disagreements on operations, policies, or strategy. This follows the April 19, 2026 definitive merger agreement with SVRE Holdings Ltd. and Serra Verde Rare Earths Ltd., with plans to expand the Board to eight directors by adding two Serra Verde nominees upon closing expected in Q3 2026, subject to customary conditions and approvals.

• ·Company address: 100 W. Airport Road, Stillwater, OK 74075
• ·Trading symbol: USAR on Nasdaq Stock Market LLC
• ·Common Stock par value: $0.0001
• ·Emerging growth company: yes

23-04-2026

CS Disco, Inc. increased its Board size from nine to ten directors and appointed Toby Williams, President and CEO of Paylocity Holding Corporation, as an independent Class II director effective April 22, 2026, for a term expiring at the 2026 Annual Meeting. Mr. Williams will receive an initial $300,000 RSU equity award vesting over three years and an annual $35,000 cash retainer under the Non-Employee Director Compensation Policy. Colette Pierce Burnette, Ed.D. and Aaron Clark will not stand for reelection at the 2026 Annual Meeting, after which the Board size will reduce to eight directors.

• ·Toby Williams, age 52, previously served as Co-CEO and CFO at Paylocity, Chief Product and Strategy Officer at Ellucian, and Director of Corporate Development at Paychex.
• ·Board determined Toby Williams is independent pursuant to NYSE rules.
• ·No arrangement, understanding, family relationship, or reportable transactions under Item 404(a) of Regulation S-K with Toby Williams.
• ·Entered into standard indemnification agreement with Toby Williams.
• ·Initial RSUs vest in 12 equal quarterly installments; annual RSUs vest in 4 equal quarterly installments.
• ·Company is an emerging growth company electing not to use extended transition period for new accounting standards.

23-04-2026

Quality Industrial Corp. (QIND) announced the appointment of Carsten Kjems Falk as Chief Executive Officer following the resignation of John-Paul Backwell as CEO for personal and health reasons; both will continue as directors, with Falk also retaining his CFO role. Falk brings prior experience as the company's CEO from September 2020 to October 2022, Chief Commercial Officer until August 2025, and current Head of M&A at Fusion Fuel Green PLC. The transition emphasizes focus on execution, efficiency, and strategic priorities amid forward-looking statements noting risks.

• ·Carsten Kjems Falk served as Interim CFO and director since August 2025, Chief Commercial Officer from October 2022 to August 2025, and previous CEO from September 2020 to October 2022.
• ·Falk was CEO of Domino’s Pizza Denmark from 2013 to 2019.
• ·Annual Report on Form 10-K filed on March 31, 2026.
• ·Contact: 505 Montgomery Street, San Francisco, CA 94111; Phone: +1-800-706-0806; Website: qualityindustrialcorp.com

23-04-2026

Expedia Group, Inc. (Nasdaq: EXPE) appointed Derek Andersen as Chief Financial Officer effective May 11, 2026, succeeding Scott Schenkel, who is stepping down after 16 months of strengthening the company's financial foundation and supporting margin expansion. Schenkel will stay through the Q1 earnings call on May 7, 2026, before departing on May 16, 2026. Andersen brings extensive finance leadership from Snap Inc., Amazon.com, Inc., and Fox Interactive Media, with leadership praising the smooth transition and future growth potential.

• ·Derek Andersen served as CFO of Snap Inc. from May 2019 through April 2026 and VP of Finance since July 2018.
• ·Andersen held finance roles at Amazon.com, Inc. from March 2011 to June 2018, including VP of Finance for digital video.
• ·Expedia Group helps millions of travelers in more than 70 countries.

23-04-2026

Clean Energy Fuels Corp. (NASDAQ: CLNE) announced the appointment of Clay Corbus as President and Chief Executive Officer, effective immediately, succeeding Andrew Littlefair, who transitions to a non-employee government relations consultant while remaining on the board. Corbus, with 19 years of experience at the company including leadership in corporate strategy, M&A, capital-raising, and RNG production/distribution, also joins the board. The board highlighted Corbus's strategic expertise for growth and long-term value, with no reported disruptions in the leadership transition.

• ·Appointment effective April 23, 2026.
• ·Corbus graduated from Dartmouth College (AB in Government) and Columbia University (MBA in Finance).
• ·Littlefair co-founded Clean Energy with Boone Pickens.
• ·Media contact: Kimberly Fleer (1-949-437-1447); Investor contact: Thomas Driscoll (1-949-437-1191).

23-04-2026

On April 21, 2026, David Halstead resigned as Chief Financial Officer and Board member of Graphene & Solar Technologies Ltd, effective immediately, with no disagreements on operations, policies, or practices. The Board appointed Kristine Woo as interim CFO effective the same date, planning a search for a permanent successor, with compensation per executive policies. There are no related arrangements, family ties, or disclosable transactions for Woo.

• ·Company is an emerging growth company.
• ·No securities registered under Section 12(b).
• ·Headquartered at 11201 North Tatum Blvd., Suite 300, Phoenix, AZ 85028.

23-04-2026

On April 17, 2026, the Board of Directors of Columbia Financial, Inc. designated Thomas Splaine, Jr., Executive Vice President and Chief Financial Officer, as the company's principal financial officer and principal accounting officer for SEC reporting matters. This designation follows his appointment as EVP and CFO effective January 28, 2026, in connection with Dennis E. Gibney's promotion to First Senior Executive Vice President and Chief Banking Officer. The filing includes no financial data or other material changes.

• ·Filing signed by Thomas F. Splaine, Jr. on April 23, 2026
• ·Company incorporated in Delaware; IRS Employer Identification Number: 22-3504946